JP2024541315A5 - - Google Patents
Info
- Publication number
- JP2024541315A5 JP2024541315A5 JP2024527312A JP2024527312A JP2024541315A5 JP 2024541315 A5 JP2024541315 A5 JP 2024541315A5 JP 2024527312 A JP2024527312 A JP 2024527312A JP 2024527312 A JP2024527312 A JP 2024527312A JP 2024541315 A5 JP2024541315 A5 JP 2024541315A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- pharmaceutically acceptable
- acceptable salt
- nri
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278324P | 2021-11-11 | 2021-11-11 | |
| US63/278,324 | 2021-11-11 | ||
| US202263305305P | 2022-02-01 | 2022-02-01 | |
| US63/305,305 | 2022-02-01 | ||
| PCT/US2022/049483 WO2023086433A1 (en) | 2021-11-11 | 2022-11-10 | Methods and compositions for treating conditions associated with central hypoventilation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024541315A JP2024541315A (ja) | 2024-11-08 |
| JP2024541315A5 true JP2024541315A5 (cg-RX-API-DMAC7.html) | 2025-11-17 |
Family
ID=84627454
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024527312A Pending JP2024541315A (ja) | 2021-11-11 | 2022-11-10 | 中枢性低換気に関連する状態を治療するための方法および組成物 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250000823A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4429649A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024541315A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240108453A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022387440A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3237151A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL312688A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024005600A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023086433A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025207125A1 (en) * | 2024-03-26 | 2025-10-02 | The Regents Of The University Of California | Combination pharmacological interventions for obstructive sleep apnea |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| EP3685858A1 (en) * | 2019-01-24 | 2020-07-29 | Assistance Publique-Hopitaux De Paris | A noradrenergic system stimulator in the treatment of central hypoventilation syndromes |
| US20220362221A1 (en) * | 2019-11-04 | 2022-11-17 | Apnimed, Inc. (Delaware) | Combination pharmacological interventions for multiple mechanisms of obstructive sleep apnea |
-
2022
- 2022-11-10 MX MX2024005600A patent/MX2024005600A/es unknown
- 2022-11-10 US US18/709,055 patent/US20250000823A1/en active Pending
- 2022-11-10 KR KR1020247019140A patent/KR20240108453A/ko active Pending
- 2022-11-10 EP EP22830640.3A patent/EP4429649A1/en active Pending
- 2022-11-10 IL IL312688A patent/IL312688A/en unknown
- 2022-11-10 AU AU2022387440A patent/AU2022387440A1/en active Pending
- 2022-11-10 JP JP2024527312A patent/JP2024541315A/ja active Pending
- 2022-11-10 WO PCT/US2022/049483 patent/WO2023086433A1/en not_active Ceased
- 2022-11-10 CA CA3237151A patent/CA3237151A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2378255T3 (es) | Titulación de tapentadol | |
| US10881657B2 (en) | Bupropion as a modulator of drug activity | |
| ES2304041T3 (es) | Nuevos tratamientos que utilizan derivados de fenetilamina. | |
| US10092561B2 (en) | Compositions and methods comprising bupropion or related compounds for sustained delivery of dextromethorphan | |
| US10058518B2 (en) | Bupropion as a modulator of drug activity | |
| US10105327B2 (en) | Compositions and methods for increasing the metabolic lifetime of dextromethorphane and related pharmacodynamic effects | |
| US20200022929A1 (en) | Bupropion as a modulator of drug activity | |
| TWI312285B (en) | Methods of treatment using a gastric retained gabapentin dosage | |
| US9700553B2 (en) | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | |
| US20190192507A1 (en) | Bupropion as a modulator of drug activity | |
| US20190142768A1 (en) | Bupropion as a modulator of drug activity | |
| US20200129474A1 (en) | Combination therapy for effecting weight loss and treating obesity | |
| US20170304298A1 (en) | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects | |
| KR20090090316A (ko) | 체중 감량 약물을 투여하기 위한 단위 용량 팩키지 및 투여 방법 | |
| US20160317476A1 (en) | Compositions and Methods for Increasing the Metabolic Lifetime of Dextromethorphan and Related Pharmacodynamic Effects | |
| US20220211678A1 (en) | Uses of (+)-a-dihydrotetrabenazine in methods of treating movement disorder | |
| JP2025084754A5 (cg-RX-API-DMAC7.html) | ||
| JP2007533733A (ja) | 食物摂取管理の方法 | |
| JP2022519721A5 (cg-RX-API-DMAC7.html) | ||
| JP2025508406A5 (cg-RX-API-DMAC7.html) | ||
| CA2485736A1 (en) | Methods of treating gastrointestinal and genitourinary pain disorders using venlafaxine and derivatives | |
| JP2020533415A (ja) | ナルコレプシーの処置におけるガボキサドールの使用 | |
| TW200835477A (en) | Methods for treating depression | |
| EP2089022A2 (en) | Composition containing a mixture of antidepressants for treating premature ejaculation | |
| CN114786668B (zh) | 用于治疗抑郁症的环丝氨酸和锂的组合疗法 |